Henrik Luessen work email
- Valid
- Valid
Henrik Luessen personal email
Henrik Luessen is a Founder and Managing Director at Tytonis BV at eleva. He possess expertise in pharmaceutical industry, technology transfer, biotechnology, drug development, drug delivery and 45 more skills. He is proficient in English, German and Dutch.
-
Managing DirectorTytonis B.V. Jan 2006 - PresentNetherlandsTytonis is a network organisation consisting of a multidisciplinary team of about 14 former pharma executives covering the areas of licensing, M&A, business/corporate development, communication strategy, patents, legal, project management, QA and regulatory.
-
Chief Business Officer (External)Eleva Jun 2023 - PresentFreiburg, Baden-Württemberg, GermanyEleva is the inventor of their proprietary Bryotechnology-TM moss-based fermentation process allowing for human-like glycolisation pattern. Besides CDMO collaborations they offer two unique proprietary products developed to 2000 liter GMP scale, of which a) alpha galactosidase A has successfully completed a clinical phase 1b study, and b) recombinant human Factor H entering clinical phase 1b studies towards mid 2024.
-
Co-Founder And Managing DirectorIca Aesthetic Navigation Gmbh Oct 2014 - PresentWiesbaden, GermanyICA Aesthetic Navigation GmbH is developing new personal assessment tools in the fields of aesthetic and medical dermatology.
-
Chief Business OfficerSapreme Technologies Bv Jan 2021 - Jun 2023Utrecht, NetherlandsSapreme Technologies has invented and developed its unique endosomal escape platform to allow drugs safe and targeted delivery to the cytosolic compartment. -
Co-Founder And External Business AdvisorAtriva Therapeutics Gmbh Apr 2015 - Dec 2020TuebingenAtriva Therapeutics is a new venture developing its proprietary MEK inhibitor platform to treat influenza infections. Currently the company seeks external funding to bring its compounds into the clinic. The charming aspect is that the compounds that have shown impressive results in preclinical studies are readily available through repurposing of existing, clinical proven, resp. marketed drug compounds.
-
Chief Business OfficerPromethera Biosciences Feb 2017 - Jan 2020Mont Saint Guibert, Belgium -
Member Of The Supervisory BoardXenikos Bv Jul 2012 - May 2018Nijmegen, NetherlandsXenikos is developing a new, life-saving therapy for corticosteroid resistant aGVHD (Orphan) based on a combination of two toxin (ricin-A) conjugated antibodies targeting either CD-3 or CD-7. The company is currently in ongoing clinical 2a studies with and reached a very positive interim result.
-
Chief Business Officer (Interim)Activaero Gmbh May 2009 - Jun 2012Beside my current position at Tytonis BV I was also appointed as CBO of Activaero on a part-time basis. It is a great company to be with and I am very much looking forward as part of the team to develop this company to become the world leader in inhalation therapy. -
CboInscreenex Gmbh Jun 2010 - Dec 2011After being involved in the foundation process of InSCREENeX as a spin-out from the Helmholtz Center in Brunswig I joined as their CBO to promote their proprietary platforms Screenflex-TM and CI-Screen-TM. Our goal is to establish InSCREENeX as a market leader in advanced cell-based tox and compound screening technologies.
-
Director Business & Corporate DevelopmentOctoplus Jan 1999 - Dec 2005Responsible for commercial deveolpment of the company. Started when 16 employees present and left when 140 employees in the company. Activities include: Corporate strategy, licensing, M&A's, portfolio management, pharmaceutical development & drug delivery -
Manager Corporate DevelopmentLts Lohmann Therapy Systems Gmbh Oct 1996 - Dec 1998Responsible for licensing of oral, skin care and environmental care products, co-responsible for Corporate Strategy, responsible for business development Asia -
Ph.D. StudentLeiden University 1992 - 1996Leiden, South Holland, Netherlands
Henrik Luessen Skills
Henrik Luessen Education Details
-
Pharmaceutics
-
Pharmaceutical Sciences
Frequently Asked Questions about Henrik Luessen
What company does Henrik Luessen work for?
Henrik Luessen works for Eleva
What is Henrik Luessen's role at the current company?
Henrik Luessen's current role is Founder and Managing Director at Tytonis BV.
What is Henrik Luessen's email address?
Henrik Luessen's email address is he****@****era.com
What schools did Henrik Luessen attend?
Henrik Luessen attended Leiden University, Universität Hamburg.
What are some of Henrik Luessen's interests?
Henrik Luessen has interest in Business Strategy, Educationprivate, Bicyling, Dancing, Technology Scouting, Education Private, Nature, Licensing, Hunting.
What skills is Henrik Luessen known for?
Henrik Luessen has skills like Pharmaceutical Industry, Technology Transfer, Biotechnology, Drug Development, Drug Delivery, Strategy, Biopharmaceuticals, Clinical Development, Lifesciences, R&d, Commercialization, Regulatory Affairs.
Who are Henrik Luessen's colleagues?
Henrik Luessen's colleagues are Maja Delic, Manuela Wassermann-Heitzler, Katharina Binder, Christian Sievert, Benjamin Fode, Jonas Schweigel, Judith H..
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial